Lucas Catherine, Donovan Peter
Department of Clinical Pharmacology, Royal Brisbane and Women's Hospital, Brisbane, Queensland.
Aust Fam Physician. 2013 Jan-Feb;42(1-2):18-22.
Therapeutic drug monitoring, the measurement of plasma or blood concentrations of a medication to assist the management of patients, is commonly performed by general practitioners and specialists alike. However, established therapeutic ranges are only available for a limited number of medications.
This article outlines the basics of therapeutic drug monitoring,including the drugs for which monitoring is suitable and when, how and why it should be performed in general practice.
Therapeutic drug monitoring is generally only indicated when medications have specific characteristics (eg. a narrow therapeutic index), where there is an established therapeutic range, where the consequences of undertreatment cannot be recognised clinically and can be serious (eg. seizure) and/or if toxicity is suspected. Commonly used medications where therapeutic drug monitoring is indicated include some antiepileptic drugs (eg. phenytoin, carbamazepine), lithium and digoxin. For the majority of medications, therapeutic drug monitoring is unlikely to assist management and should not be performed.
治疗药物监测,即测量血浆或血液中药物浓度以辅助患者管理,通常由全科医生和专科医生共同进行。然而,既定的治疗范围仅适用于有限数量的药物。
本文概述了治疗药物监测的基础知识,包括适合监测的药物、何时、如何以及为何应在全科医疗中进行监测。
治疗药物监测通常仅在药物具有特定特征(例如治疗指数狭窄)、存在既定治疗范围、治疗不足的后果无法通过临床识别且可能很严重(例如癫痫发作)和/或怀疑有毒性时才适用。需要进行治疗药物监测的常用药物包括一些抗癫痫药物(例如苯妥英、卡马西平)、锂盐和地高辛。对于大多数药物,治疗药物监测不太可能有助于管理,不应进行。